The symposium brought together experts from the government, non-governmental organizations, affected counties in Kenya, regional experts in neglected tropical diseases and research institutions to discuss innovative ways of increasing access to treatments for neglected diseases once trials are successfully completed.
Flyer
DNDi Access Symposium Report held during ASTMH in Kenya
Symposium
Innovation for Access to Treatment for Neglected Diseases
Chair: Monique Wasunna, Director, DNDi Africa Regional Office
| Welcome and Introductions Monique Wasunna, Director, DNDi Africa Regional Office |
| Linking innovation to access to treatments for neglected patients Eric Stobbaerts, DNDi |
| Visceral Leishmaniasis treatment access: The reality on the ground Margriet den Boer, KalaCore Regional Coordinator, East Africa |
| Challenges of access to treatment for neglected diseases – Experiences in Kenya Hardley Sultani Matendechero, Head, NTD Programme, Ministry of Health |
| SSG & PM: Issues of access to VL treatments Robert Kimutai, Clinical Trial Manager, DNDi Africa Regional Office |
| Role of stakeholders in making NTD drugs available Joyce Onsongo, Disease Control and Prevention Officer, WHO |
| Patient experiences in access to VL treatment Former VL Patient & Latin America patient perspective video |
| Wrap up, discussions, way forward and conclusions Eric Stobbaerts & Monique Wasunna |
More information: KEMRI Website
